Cargando…
Evaluation of the Xpert Flu A Panel nucleic acid amplification-based point-of-care test for influenza A virus detection and pandemic H1 subtyping
BACKGROUND: Influenza antigenic point-of-care (POC) tests are too insensitive for individual reliable diagnosis of influenza virus infections without additional laboratory confirmation. Molecular POC tests could be a valuable alternative. OBJECTIVES: To evaluate the first influenza molecular POC tes...
Autores principales: | Jenny, Shireen L., Hu, Yaobi, Overduin, Pieter, Meijer, Adam |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7108229/ https://www.ncbi.nlm.nih.gov/pubmed/20674478 http://dx.doi.org/10.1016/j.jcv.2010.07.005 |
Ejemplares similares
-
Comparison of the ID Now Influenza A & B 2, Cobas Influenza A/B, and Xpert Xpress Flu Point-of-Care Nucleic Acid Amplification Tests for Influenza A/B Virus Detection in Children
por: Kanwar, Neena, et al.
Publicado: (2020) -
Real-time Laboratory-Based Influenza Surveillance with Xpert
Flu
por: Dugas, Andrea, et al.
Publicado: (2015) -
Multi-center evaluation of Cepheid Xpert® Xpress SARS-CoV-2/Flu/RSV molecular point-of-care test
por: Sluimer, John, et al.
Publicado: (2021) -
Necessity to critically review the automatic results of the Xpert Flu assay
por: Engelmann, Ilka, et al.
Publicado: (2017) -
Clinical evaluation of the GeneXpert® Xpert® Xpress SARS-CoV-2/Flu/RSV combination test
por: Johnson, Grant, et al.
Publicado: (2021)